Jupiter Neurosciences (JUNS) Inventory (2025)
Jupiter Neurosciences (JUNS) posted quarterly Inventory of $159790.0 for Q4 2025.
Jupiter Neurosciences (JUNS) Inventory (2025) Analysis & Trends
Jupiter Neurosciences (JUNS) has reported Inventory for 1 consecutive years, with $159790.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Inventory changed N/A year-over-year to $159790.0; the TTM figure through Dec 2025 stood at $159790.0 (changed N/A YoY), while the FY2025 annual figure was $159790.0, changed N/A from the prior year.
- Inventory was little changed at $159790.0 in Q4 2025 per JUNS's latest filing.
- Across five years, Inventory topped out at $159790.0 in Q4 2025 and bottomed at $159790.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Jupiter Neurosciences | 3.37 Mn | 1.85 Mn | 21,064.00 | 135,290.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 159,790.00 |